Efficacy of Second-Line ICIs Combined with TKIs among Patients with Metastatic Renal Cell Carcinoma: A Real-World StudyHaoran Zhang, Pengfei Shen, Xudong Zhu et al.|Immunotherapy|2022Cited by 2